Rossby Financial’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
QF
FCM
Rossby Financial's ROIV Position: Q2 2026 in Review
Rossby Financial increased its Roivant Sciences (ROIV) stake by 54% in Q2 2026, buying an estimated $2.01K and bringing the position to 194 shares worth $6.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1310.
Rossby Financial first reported a position in ROIV in Q2 2025 and has held it in 5 quarters since. The position peaked at $158K in Q3 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.
- Rossby Financial held 194 shares of Roivant Sciences worth $6.87K as of Q2 2026.
- Rossby Financial bought 68 Roivant Sciences shares in Q2 2026, an estimated $2.01K.
- Roivant Sciences made up ﹤0.01% of Rossby Financial's portfolio in Q2 2026, its #1310 holding.
- Rossby Financial first reported a position in Roivant Sciences in Q2 2025 and has held it in 5 quarters since.
- Rossby Financial's Roivant Sciences position peaked at $158K in Q3 2025.
- 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.
Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.